Latanoprost/timolol

Latanoprost/timolol, sold under the brand name Xalacom, is a combination drug used for the treatment of glaucoma, consisting of latanoprost (increase uveoscleral outflow of aqueous humor ) and timolol (a beta blocker decreasing the production of aqueous fluid).

Brand names
In some countries, Xalacom is marketed by Viatris after Upjohn was spun off from Pfizer.